News

Pfizer (PFE) Reports XTANDI Shows Life-Extending Benefits
Pfizer Inc. (NYSE:PFE) is one of the 13 Best Large Cap Stocks to Buy Right Now. On July 10, Pfizer Inc. (NYSE:PFE) shared ...
Pfizer and Astellas’ Xtandi improves OS as combination therapy
Pfizer and Astellas’ Xtandi (enzalutamide) has improved overall survival (OS) in patients with non-metastatic ...
MedPage Today on MSN3d
Psychological Stress and Cancer; H. Pylori Still a Risk; Cancer Lessons from Turtles
Psychological stress may increase the risk of cancer in BRCA mutation carriers. (British Journal of Cancer) Former Major League Baseball All-Star pitcher Bobby Jenks, 44, a member of the 2005 Chicago ...
Applied Clinical Trials Online3d
EMBARK Trial Shows Xtandi Combination Demonstrates Significant Overall Response in Non-Metastatic Hormone-Sensitive Prostate Cancer
Results from the Phase III EMBARK trial show that in combination with leuprolide, Xtandi (enzalutamide) demonstrated a ...
Pfizer, Astellas Report Xtandi Survival Win In Prostate Cancer Study
Xtandi plus leuprolide improved overall survival in prostate cancer patients in the Phase 3 EMBARK trial, with no new safety ...
CURE3d
Erleada May Be a New Standard of Care for Some With Prostate Cancer
Real-world data suggest that Erleada may offer an advantage over other treatment options for patients with metastatic ...
thederrick.com3d
Natanael Cano expands his sound with new album, 'Porque La Demora'
Natanael Cano explores new musical styles in his latest album, "Porque La Demora." Known for his corridos tumbados, Cano ...
Pfizer, Astellas say Xtandi regimen hit secondary goal in late-stage trial for prostate cancer
Pfizer (PFE) stock in focus as the company with Astellas Pharma (ALPMF) (ALPMY) announce a Phase 3 trial win for their ...
Factbox-Major Deals Involving U.S. Drugmakers and Biotechs Over the Past Decade
Globally, $105.3 billion worth of pharmaceuticals and biotech M&A deals have been inked so far in 2025, according to data ...
Merck Faces Multiple Challenges: Will It Steer Through Successfully?
Merck MRK is expected to face several hurdles over the next few years that could affect its long-term growth trajectory, ...
Zacks Investment Research on MSN4d
JNJ vs. Pfizer: Which Pharma Giant is the Better Investment Now?
Johnson & Johnson JNJ and Pfizer PFE rank among the world’s largest pharmaceutical companies, each with broad and diversified ...
Your Good Health: Man’s PSA level skyrockets, making cancer recurrence likely
I am sorry, but it is very likely that the cancer has come back somewhere in your body. However, this is not 100 per cent ...